Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction.

Fiorentino TV, Marini MA, Succurro E, Sciacqua A, Andreozzi F, Perticone F, Sesti G.

Oncotarget. 2017 Jun 19;8(45):79576-79586. doi: 10.18632/oncotarget.18572. eCollection 2017 Oct 3.

2.

Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers.

Kubo Y, Imaizumi T, Ando M, Nakatochi M, Yasuda Y, Honda H, Kuwatsuka Y, Kato S, Kikuchi K, Kondo T, Iwata M, Nakashima T, Yasui H, Takamatsu H, Okajima H, Yoshida Y, Maruyama S.

PLoS One. 2017 Oct 10;12(10):e0185476. doi: 10.1371/journal.pone.0185476. eCollection 2017.

3.

Increased risk of chronic kidney disease in patients with rosacea: A nationwide population-based matched cohort study.

Chiu HY, Huang WY, Ho CH, Wang JJ, Lin SJ, Hsu YW, Chen PJ.

PLoS One. 2017 Oct 2;12(10):e0180446. doi: 10.1371/journal.pone.0180446. eCollection 2017.

4.

Cooperative stimulation of atherogenesis by lipopolysaccharide and palmitic acid-rich high fat diet in low-density lipoprotein receptor-deficient mice.

Lu Z, Li Y, Brinson CW, Lopes-Virella MF, Huang Y.

Atherosclerosis. 2017 Oct;265:231-241. doi: 10.1016/j.atherosclerosis.2017.09.008. Epub 2017 Sep 9.

PMID:
28934649
5.

The LRP1 Gene Polymorphism is associated with Increased Risk of Metabolic Syndrome Prevalence in the Serbian Population.

Vučinić N, Stokić E, Djan I, Obreht D, Veličković N, Stankov K, Djan M.

Balkan J Med Genet. 2017 Jun 30;20(1):51-58. doi: 10.1515/bjmg-2017-0004. eCollection 2017 Jun 30.

6.

Inverse Associations between a Locally Validated Mediterranean Diet Index, Overweight/Obesity, and Metabolic Syndrome in Chilean Adults.

Echeverría G, McGee EE, Urquiaga I, Jiménez P, D'Acuña S, Villarroel L, Velasco N, Leighton F, Rigotti A.

Nutrients. 2017 Aug 11;9(8). pii: E862. doi: 10.3390/nu9080862.

7.

Prevalence of Metabolic Syndrome Among the End-Stage Renal Disease Patients on Hemodialysis.

Alswat KA, Althobaiti A, Alsaadi K, Alkhaldi AS, Alharthi MM, Abuharba WA, Alzaidi AA.

J Clin Med Res. 2017 Aug;9(8):687-694. doi: 10.14740/jocmr3064w. Epub 2017 Jul 1.

8.

Pre-sarcopenia is associated with renal hyperfiltration independent of obesity or insulin resistance: Nationwide Surveys (KNHANES 2008-2011).

Han E, Lee YH, Lee BW, Kang ES, Cha BS.

Medicine (Baltimore). 2017 Jun;96(26):e7165. doi: 10.1097/MD.0000000000007165.

9.

Metabolic syndrome is independently associated with a mildly reduced estimated glomerular filtration rate: a cross-sectional study.

Hu W, Wu XJ, Ni YJ, Hao HR, Yu WN, Zhou HW.

BMC Nephrol. 2017 Jun 13;18(1):192. doi: 10.1186/s12882-017-0597-3.

10.

Metabolic injury-induced NLRP3 inflammasome activation dampens phospholipid degradation.

Rampanelli E, Orsó E, Ochodnicky P, Liebisch G, Bakker PJ, Claessen N, Butter LM, van den Bergh Weerman MA, Florquin S, Schmitz G, Leemans JC.

Sci Rep. 2017 Jun 6;7(1):2861. doi: 10.1038/s41598-017-01994-9.

11.

Relation between metabolic syndrome and body compositions among Chinese adolescents and adults from a large-scale population survey.

Xu T, Liu J, Liu J, Zhu G, Han S.

BMC Public Health. 2017 Apr 20;17(1):337. doi: 10.1186/s12889-017-4238-3.

12.

Retinol Binding Protein-4 Levels and Non-alcoholic Fatty Liver Disease: A community-based cross-sectional study.

Chen X, Shen T, Li Q, Chen X, Li Y, Li D, Chen G, Ling W, Chen YM.

Sci Rep. 2017 Mar 23;7:45100. doi: 10.1038/srep45100.

13.

Metabolic syndrome and masked hypertension among African Americans: The Jackson Heart Study.

Colantonio LD, Anstey DE, Carson AP, Ogedegbe G, Abdalla M, Sims M, Shimbo D, Muntner P.

J Clin Hypertens (Greenwich). 2017 Jun;19(6):592-600. doi: 10.1111/jch.12974. Epub 2017 Feb 6.

15.

Baseline General Characteristics of the Korean Chronic Kidney Disease: Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).

Kang E, Han M, Kim H, Park SK, Lee J, Hyun YY, Kim YS, Chung W, Kim HJ, Oh YK, Ahn C, Oh KH.

J Korean Med Sci. 2017 Feb;32(2):221-230. doi: 10.3346/jkms.2017.32.2.221.

16.

The metabolic syndrome and chronic kidney disease.

Zhang X, Lerman LO.

Transl Res. 2017 May;183:14-25. doi: 10.1016/j.trsl.2016.12.004. Epub 2016 Dec 9. Review.

PMID:
28025032
17.

Prevalence of obesity and risk of chronic kidney disease among young adults in Egypt.

Fouad M, Ismail MI, Gaballah A, Reyad E, ELdeeb S.

Indian J Nephrol. 2016 Nov-Dec;26(6):413-418.

18.

Energy-dense diets increase FGF23, lead to phosphorus retention and promote vascular calcifications in rats.

Raya AI, Rios R, Pineda C, Rodriguez-Ortiz ME, Diez E, Almaden Y, Muñoz-Castañeda JR, Rodriguez M, Aguilera-Tejero E, Lopez I.

Sci Rep. 2016 Nov 14;6:36881. doi: 10.1038/srep36881.

19.

Cardiovascular metabolic risk factors and glomerular filtration rate: a rural Chinese population study.

Zheng W, Qian G, Hao W, Geng X, Hong Q, Cai G, Chen X, Wu D.

Lipids Health Dis. 2016 Oct 12;15(1):180.

20.

Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.

Weber GJ, Pushpakumar S, Tyagi SC, Sen U.

Pharmacol Res. 2016 Nov;113(Pt A):300-312. doi: 10.1016/j.phrs.2016.09.002. Epub 2016 Sep 4. Review.

Supplemental Content

Support Center